Pfizer Inc – Strategy, SWOT and Corporate Finance Report

Pfizer Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, immune disorders and rare diseases, besides vaccines. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription medicines through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the North America, South America, Asia-Pacific, Australia, Europe, Africa and the Middle East. Pfizer is headquartered in New York, the US.

Scope

Detailed information on Pfizer Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Pfizer Inc in the form of a SWOT analysis

An in-depth view of the business model of Pfizer Inc including a breakdown and examination of key business segments

News about Pfizer Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Pfizer Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Pfizer Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Pfizer Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

The Procter & Gamble Co

Sanofi

Novartis AG

Merck & Co Inc

Johnson & Johnson

GlaxoSmithKline Plc

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Bristol-Myers Squibb Co

AstraZeneca Plc

Amgen Inc

AbbVie Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Pfizer Inc - Key Facts

Pfizer Inc - Key Employees

Pfizer Inc - Key Employee Biographies

Pfizer Inc - Major Products and Services

Pfizer Inc - History

Pfizer Inc - Company Statement

Pfizer Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 Company Analysis

Company Overview

Pfizer Inc - Business Description

Business Segment: Essential Health (EH)

Overview

Performance

Business Segment: Innovative Health (IH)

Overview

Performance

Geographical Segment: Developed Europe

Target Markets

Performance

Geographical Segment: Developed Rest of World

Target Markets

Performance

Geographical Segment: Emerging Markets

Target Markets

Performance

Geographical Segment: United States

Performance

R&D Overview

Pfizer Inc - Corporate Strategy

Pfizer Inc - SWOT Analysis

SWOT Analysis - Overview

Pfizer Inc - Strengths

Pfizer Inc - Weaknesses

Pfizer Inc - Opportunities

Pfizer Inc - Threats

Pfizer Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Pfizer Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Mar 21, 2019: Pfizer and Vivet Therapeutics to collaborate on Wilson disease therapy

Mar 20, 2019: Published on: 20 March 2019 Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics

Mar 15, 2019: Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)

Mar 11, 2019: Pfizer gets FDA approval for oncology biosimilar Trazimera

Mar 11, 2019: Pfizer s Herceptin Biosimilar gets FDA Approval as US Entry Nears

Mar 08, 2019: EUROPEAN MEDICINES AGENCY VALIDATES APPLICATION FOR BAVENCIO® (AVELUMAB) PLUS INLYTA® (AXITINIB) FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA

Mar 06, 2019: Pfizer licences type 1 diabetes therapy from AnTolRx

Mar 01, 2019: Pfizer Receives Positive CHMP Opinion for LORVIQUAÂ lorlatinib for Certain Adult Patients with PreviouslyTreated ALKPositive Advanced NonSmall Cell Lung Cancer

Feb 27, 2019: Top pharma executives testify before US Senate over high prices

Feb 27, 2019: Study Identifies Predictors of Psychiatric Events During Drug-Assisted Smoking Cessation

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

Pfizer Inc, Key Facts

Pfizer Inc, Key Employees

Pfizer Inc, Key Employee Biographies

Pfizer Inc, Major Products and Services

Pfizer Inc, History

Pfizer Inc, Subsidiaries

Pfizer Inc, Joint Venture

Pfizer Inc, Key Competitors

Pfizer Inc, Ratios based on current share price

Pfizer Inc, Annual Ratios

Pfizer Inc, Annual Ratios (Cont…1)

Pfizer Inc, Annual Ratios (Cont…2)

Pfizer Inc, Interim Ratios

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Pfizer Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Pfizer Inc, Performance Chart (2014 – 2018)

Pfizer Inc, Ratio Charts

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports